Page last updated: 2024-11-05

ticlopidine and Erythermalgia

ticlopidine has been researched along with Erythermalgia in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
"Erythromelalgia is a kind of cutaneous manifestation, which appears as a thrombotic complication in patients with myeloproliferative disorders such as essential thrombocythemia and polycythemia vera."1.33Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis. ( Hur, JW; Jun, JB; Lee, WS; Lee, YY, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hur, JW1
Lee, YY1
Lee, WS1
Jun, JB1

Other Studies

1 other study available for ticlopidine and Erythermalgia

ArticleYear
Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis.
    Rheumatology international, 2005, Volume: 26, Issue:1

    Topics: Adult; Angiography; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Marrow; Clopidogrel; Diag

2005